Literature DB >> 19662486

Comparison of the effects of short- and long-pulse durations when using a 585-nm pulsed dye laser in the treatment of new surgical scars.

Keyvan Nouri1, Mohamed L Elsaie, Voraphol Vejjabhinanta, Mark Stevens, Shalu S Patel, Caroline Caperton, George Elgart.   

Abstract

More than 70 million surgical procedures are performed annually in the USA with the majority involving a skin lesion and almost all individuals in their lifetime will have one or more surgical procedures resulting in scars. Patients and physicians alike are thereby motivated to improve the cosmetic outcome of scars. Prior studies have shown that the pulsed dye laser (PDL) is effective in improving the quality and appearance of the scar when using the 585-nm PDL immediately after the removal of sutures. Most published studies used a pulse duration of 450 micros, which along with the other study parameters, has led to an overall improvement of the scars. However, a pulse duration of 1.5 ms is also available when using the pulsed dye laser and it should theoretically cause fewer side-effects. To our knowledge, there are no other studies comparing the effectiveness of different pulse durations in the treatment of surgical scars starting on the day of suture removal. The purpose of this study is to compare the effect of different pulse durations (450 micros vs. 1.5 ms) in the treatments of postsurgical linear scars immediately after suture removal when using the 585-nm pulsed dye laser (PDL). Twenty non-hospitalized male and female patients (older than 18 years of age) with skin types I-IV and with postoperative linear scars measuring at least 2.1 cm were enrolled in this prospective study. Scars were randomly divided into three equal sections. The different fields were randomly chosen to receive treatment (two out of three fields) or remain as control (one field). The two fields chosen to be treated received treatment with the 585-nm PDL using a 7-mm spot size at 4.0 J. One of the treated sections was randomly selected to receive a pulse duration of 450 micros, and the other section to receive a 1.5-ms pulse. The remaining scar section was designated as control (no treatment). The three sections were mapped and recorded. The patient received treatment immediately after the sutures were removed from the wound and then monthly for 3 months. Evaluations were performed before each treatment and 1 month after the last treatment. The short-pulse and long-pulse 585-nm PDL-treated sections demonstrated a statistically significant overall average improvement of the VSS of 92 and 89%, respectively, compared to 67% for the control site (Fig. 1). Further, for individual parameters of the Vancouver scar scale (VSS), there were significant (p < 0.05) differences between control and treatment groups for all parameters, but there were no differences between the short- and long-pulse treatment groups for any parameter. Both short-pulse and long-pulse PDL are safe and effective in improving the quality and cosmetic appearance of surgical scars in skin type's I-IV starting on the day of suture removal with no significant difference between the two pulse durations.

Entities:  

Mesh:

Year:  2009        PMID: 19662486     DOI: 10.1007/s10103-009-0710-3

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  15 in total

1.  585-nm pulsed dye laser in the treatment of surgical scars starting on the suture removal day.

Authors:  Keyvan Nouri; Gloria P Jimenez; Catherine Harrison-Balestra; George W Elgart
Journal:  Dermatol Surg       Date:  2003-01       Impact factor: 3.398

Review 2.  Extracellular matrix remodelling: the role of matrix metalloproteinases.

Authors:  Ivan Stamenkovic
Journal:  J Pathol       Date:  2003-07       Impact factor: 7.996

Review 3.  Pulsed dye laser: what's new in non-vascular lesions?

Authors:  S Karsai; S Roos; S Hammes; C Raulin
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-08       Impact factor: 6.166

4.  Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.

Authors:  Oliver Bock; Haiyan Yu; Swantje Zitron; Ardeshir Bayat; Mark W J Ferguson; Ulrich Mrowietz
Journal:  Acta Derm Venereol       Date:  2005       Impact factor: 4.437

5.  Energy density and numbers of treatment affect response of keloidal and hypertrophic sternotomy scars to the 585-nm flashlamp-pumped pulsed-dye laser.

Authors:  W Manuskiatti; R E Fitzpatrick; M P Goldman
Journal:  J Am Acad Dermatol       Date:  2001-10       Impact factor: 11.527

6.  Improvement of erythematous and hypertrophic scars by the 585-nm flashlamp-pumped pulsed dye laser.

Authors:  T S Alster
Journal:  Ann Plast Surg       Date:  1994-02       Impact factor: 1.539

7.  Prevention of unfavorable scars using early pulse dye laser treatments: a preliminary report.

Authors:  J B McCraw; J A McCraw; A McMellin; N Bettencourt
Journal:  Ann Plast Surg       Date:  1999-01       Impact factor: 1.539

8.  Comparison of the effectiveness of the pulsed dye laser 585 nm versus 595 nm in the treatment of new surgical scars.

Authors:  Keyvan Nouri; Maria Patricia Rivas; Mark Stevens; Christopher J Ballard; Lauren Singer; Fangchao Ma; Voraphol Vejjabhinanta; Mohamed L Elsaie; George W Elgart
Journal:  Lasers Med Sci       Date:  2009-07-02       Impact factor: 3.161

9.  The use of pulsed dye laser for the prevention and treatment of hypertrophic scars in chinese persons.

Authors:  Henry H Chan; David S Y Wong; W S Ho; L K Lam; W Wei
Journal:  Dermatol Surg       Date:  2004-07       Impact factor: 3.398

Review 10.  Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management.

Authors:  Dolores Wolfram; Alexandar Tzankov; Petra Pülzl; Hildegunde Piza-Katzer
Journal:  Dermatol Surg       Date:  2009-02       Impact factor: 3.398

View more
  9 in total

1.  Pulsed dye laser treatment with different onset times for new surgical scars: a single-blind randomized controlled trial.

Authors:  Parastoo Davari; Farzam Gorouhi; Pantea Hashemi; Fereydoun Behnia; Afsaneh Ghassemi; Mansour Nasiri-Kashani; Alireza Firooz
Journal:  Lasers Med Sci       Date:  2012-01-08       Impact factor: 3.161

Review 2.  Treatment of keloid scars using light-, laser- and energy-based devices: a contemporary review of the literature.

Authors:  E Forbat; F R Ali; F Al-Niaimi
Journal:  Lasers Med Sci       Date:  2017-10-18       Impact factor: 3.161

Review 3.  [Therapy of scars with lasers].

Authors:  G G Gauglitz; J Pötschke; M T Clementoni
Journal:  Hautarzt       Date:  2018-01       Impact factor: 0.751

4.  Comparison of the effectiveness of two fluences using long-pulsed Nd:YAG laser in the treatment of striae distensae. Histological and morphometric evaluation.

Authors:  Mohamed L Elsaie; Maha S Hussein; Abeer A Tawfik; Hanaa M Emam; Manal A Badawi; Marwa M Fawzy; Hisham A Shokeir
Journal:  Lasers Med Sci       Date:  2016-09-05       Impact factor: 3.161

Review 5.  Keloids: Current and emerging therapies.

Authors:  Nkemcho Ojeh; Ambadasu Bharatha; Uma Gaur; Andrew LeRoy Forde
Journal:  Scars Burn Heal       Date:  2020-08-10

Review 6.  Cutaneous Scarring: Basic Science, Current Treatments, and Future Directions.

Authors:  Clement D Marshall; Michael S Hu; Tripp Leavitt; Leandra A Barnes; H Peter Lorenz; Michael T Longaker
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-02-01       Impact factor: 4.730

7.  Effects of the combined PDL/Nd:YAG laser on surgical scars: vascularity and collagen changes evaluated by in vivo confocal microscopy.

Authors:  Krisztina Vas; Magdolna Gaál; Erika Varga; Réka Kovács; Balázs Bende; Adám Kocsis; Lajos Kemény
Journal:  Biomed Res Int       Date:  2014-09-09       Impact factor: 3.411

Review 8.  A clinical review of phototherapy for psoriasis.

Authors:  Ping Zhang; Mei X Wu
Journal:  Lasers Med Sci       Date:  2017-10-24       Impact factor: 3.161

9.  Physical Management of Scar Tissue: A Systematic Review and Meta-Analysis.

Authors:  Carlina Deflorin; Erich Hohenauer; Rahel Stoop; Ulrike van Daele; Ron Clijsen; Jan Taeymans
Journal:  J Altern Complement Med       Date:  2020-06-24       Impact factor: 2.579

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.